ascopubs.org

Developing cell-free DNA (cfDNA) epigenetic signature (ep-Sig) for early detection of malignant transformation of intraductal papillary mucinous neoplasms (IPMN).

The radiological morphology of mesopancreas: A new variable to predict a positive vascular margin after pancreatoduodenectomy for pancreatic ductal adenocarcinoma? This is an ASCO Meeting Abstract ...
Drexel University

The Lab of Stem-Cell Derived Organoid Models in Pancreatic Diseases and Cancer

How Do Precancerous Lesions Develop Towards Pancreatic Cancer? Pancreatic cancer is one of the deadliest diseases in United States, with a 5-year survival of 12% and is considered to be one of the ...
ascopubs.org

Impact of Adjuvant Chemotherapy on Resected Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: Results From an International Multicenter Study

Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005 This international ...
Science Daily

Biomarkers show promise for identifying early risk of pancreatic cancer

A research team has identified a set of biomarkers that could help distinguish whether cysts on the pancreas are likely to develop into cancer or remain benign. A research team at Duke Health has ...
Business Wire

Biological Dynamics to Share Data at 2023 Early Detection of Cancer Conference in London, Highlighting Value of Exosome-based Liquid Biopsy Assay in Detecting Pancreatic Cysts

SAN DIEGO--(BUSINESS WIRE)--Biological Dynamics, Inc., a leader in exosome enrichment technology for early disease detection, will present a “lightning talk” as part of the “Understanding Pre-cancers ...